FDA Peptide Category Update: Clarifying Misinformation Cole Thomas posted on the topic LinkedIn The FDA just changed the rules on peptides effective April 15, 2026. BPC 157, GHK Cu, MOTS C, and TB 500 have been removed from the Category 2 restricted compounding list. Here is what Orthopedic Use of BPC 157 Sports Med Review RFK Jr. & claimed regenerative peptides like BPC 157 The Niche BREAKING FDA UPDATE MASSIVE FOR PEPTIDES The U.S. Food & Drug Administration is reportedly reclassifying 14 peptides from Category 2 ( compounding only, no legal prescribing) into Category 1. This means BPC 157 Explained: Benefits, Safety & Oral vs Injectable Options